Screener
Eligibility screening
An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidr…
1 US site in AL
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.